龙头企业(Leading Companies)
Novaremed AG
Novaremed is a clinical-stage Swiss biopharmaceutical company focused on the development of NRD.E1, an orally active New Chemical Entity (NCE) for the treatment of Neuropathic Pain. After the relocation to Basel in 2018, Novaremed is currently preparing for a global Phase IIb study in DNP.
行业
Bio Technology (Biotech)
Life Science
Country of Origin
以色列
